Trial Profile

Registry for patients after myocardial infarction treated with antiplatelet agents in Freiburg.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 28 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
Indications Acute coronary syndromes; Ischaemic stroke; Myocardial infarction; Stent thrombosis
Focus Therapeutic Use
Acronyms MITAP

Most Recent Events

27 Apr 2015 Status changed from planning to completed, according to results published in the Thrombosis and Haemostasis.
12 Jul 2012 Additional trial identifier 193-11, acronym MITAP identified as reported by German Clinical Trials Register record.
06 Jul 2012 Planned initiation date (1 Jul 2011) added as reported by German Clinical Trials Register record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com